Next Article in Journal
Impact of STING Inflammatory Signaling during Intracellular Bacterial Infections
Next Article in Special Issue
Pax-5 Protein Expression Is Regulated by Transcriptional 3′UTR Editing
Previous Article in Journal
ROS- and Radiation Source-Dependent Modulation of Leukocyte Adhesion to Primary Microvascular Endothelial Cells
Previous Article in Special Issue
WT1-AS/IGF2BP2 Axis Is a Potential Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma According to ceRNA Network Comprehensive Analysis Combined with Experiments
Review

Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks

Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Academic Editor: Yujing Li
Cells 2022, 11(1), 73; https://doi.org/10.3390/cells11010073
Received: 10 November 2021 / Revised: 23 December 2021 / Accepted: 24 December 2021 / Published: 28 December 2021
(This article belongs to the Special Issue Non-coding RNAs: Epigenetic Players Implicated in Human Diseases)
Epithelial–mesenchymal transition (EMT) is a fundamental physiologically relevant process that occurs during morphogenesis and organ development. In a pathological setting, the transition from epithelial toward mesenchymal cell phenotype is hijacked by cancer cells, allowing uncontrolled metastatic dissemination. The competing endogenous RNA (ceRNA) hypothesis proposes a competitive environment resembling a large-scale regulatory network of gene expression circuits where alterations in the expression of both protein-coding and non-coding genes can make relevant contributions to EMT progression in cancer. The complex regulatory diversity is exerted through an array of diverse epigenetic factors, reaching beyond the transcriptional control that was previously thought to single-handedly govern metastatic dissemination. The present review aims to unravel the competitive relationships between naturally occurring ceRNA transcripts for the shared pool of the miRNA-200 family, which play a pivotal role in EMT related to cancer dissemination. Upon acquiring more knowledge and clinical evidence on non-genetic factors affecting neoplasia, modulation of the expression levels of diverse ceRNAs may allow for the development of novel prognostic/diagnostic markers and reveal potential targets for the disruption of cancer-related EMT. View Full-Text
Keywords: EMT; microRNA-200 family; ceRNA; lncRNA EMT; microRNA-200 family; ceRNA; lncRNA
Show Figures

Figure 1

MDPI and ACS Style

Uhan, S.; Hauptman, N. Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks. Cells 2022, 11, 73. https://doi.org/10.3390/cells11010073

AMA Style

Uhan S, Hauptman N. Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks. Cells. 2022; 11(1):73. https://doi.org/10.3390/cells11010073

Chicago/Turabian Style

Uhan, Sara, and Nina Hauptman. 2022. "Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks" Cells 11, no. 1: 73. https://doi.org/10.3390/cells11010073

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop